Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    24247587 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed The Transendocardial Autologous Cells (hMSC or hBMC) in Ischemic Heart Failure Trial (TAC-HFT)
Conditions: Stem Cell Transplantation;   Ventricular Dysfunction, Left
Interventions: Biological: Autologous human mesenchymal cells (hMSCs);   Biological: Autologous human bone marrow cells (hBMCs);   Biological: Placebo

Indicates status has not been verified in more than two years